Lacosamide Injection, Solution
Product Images NDC 69543-455
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 69543-455). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Virtus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure1 (Lacosamide 02)
Figure2 (Lacosamide 03)
Principal Display Panel (200mg per 20mL Label)
The text seems to be a label of a 20mL single-dose vial of Lacosamide Injection, manufactured by Virtus Pharmaceuticals LLC for intravenous use only. The label provides information about the usual dosage and storage of the medicine, as well as the lot number and expiration date. Additionally, it cautions to discard the unused portion and to keep it out of the reach of children.*
Principal Display Panel (200mg per 20mL Carton)
This appears to be a label from a medication product named "Lacosamide Injection, USP" which is meant for intravenous use only. It comes in a 200 L/18 quantity vial and includes a Medication Guide that should be issued to each patient. The label also provides a National Drug Code (NDC) of 6954345510 and a code DG G0543-485-10. There are some illegible characters and phrases in the text but the overall information is understandable.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.